Omega-3 fatty acids in senior dogs with renal or inflammatory disease require what practice?

• A. Fixed dose with no monitoring
• B. It is contraindicated
• C. Dose should be appropriate and monitored for interactions
• D. Only used during meals

Answer: (C)

Omega-3 fatty acid supplementation in senior dogs with kidney disease or inflammatory conditions should be dosed appropriately and closely monitored for interactions with other medications and the disease process. These supplements can help reduce inflammation and may have renal benefits, but their effects depend on the amount given and the dog’s overall pharmacologic context.

Why this approach fits: because omega-3s can influence how other drugs work—particularly anticoagulants or antiplatelet medications, as well as NSAIDs used for inflammation—it's important to tailor the dose to the individual dog, consider any concurrent therapies, and watch for signs of adverse effects. Monitoring helps ensure the dog benefits from the anti-inflammatory and potential renal-supportive effects without increasing risks like bleeding, gastrointestinal upset, or unexpected drug interactions.

In practice, dosing should follow product labeling and veterinary guidance, with adjustments based on response and tolerance. While giving with meals can aid absorption and reduce GI upset, the essential point is keeping the dose appropriate and monitoring for interactions and side effects over time.